Rentschler Biopharma is ceasing its cell and gene therapy operations, notably at its UK site, to focus on biologics. The company noted that the cell and gene therapy market’s growth has been slower than expected and didn’t meet the firm’s expectations. Recently, the firm has made significant investments to upgrade its capabilities and infrastructure, enabling it to concentrate on biopharmaceuticals.
Public school board investigating ‘potential cyber incident’ – Hamilton Spectator
The public school board in Hamilton is currently investigating a potential cyber incident. The details of the incident are not yet clear, but the board
